CLOV 10-Q: SEC filing
Clover Health Investments
Filed with the SEC on · accession 0001801170-26-000296
CLOV filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Clover Health Investments filed its Form 10-Q for the quarter ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification.
Summary of the filing
Clover Health Investments filed its Form 10-Q for the quarter ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the financial statements fairly present the company's financial condition and results of operations.
Key details
✦ Ask GOAX AI about this filing — what it means for CLOV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLOV?
Click hereFrequently asked questions
What did CLOV file with the SEC on Nov 6, 2026?
CLOV filed a 10-Q (SEC filing). Clover Health Investments filed its Form 10-Q for the quarter ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the financial statements fairly present the company's financial condition and results of operations.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other CLOV SEC filings
- 8-K · Guidance raiseNov 4, 2026
- 8-K · Regulatory actionOct 9, 2026
- 8-K · Board changeSep 25, 2026
- 8-K · Board changeSep 24, 2026
- 8-K · SEC filingAug 20, 2026
- 10-Q · SEC filingAug 7, 2026
- 8-K · Guidance raiseAug 5, 2026
- 8-K · Regulatory actionJul 17, 2026
- 8-K · Regulatory actionJun 18, 2026
- 8-K · Executive departureJun 16, 2026
Get alerts when CLOV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days